Meridian Bioscience | VIVO

Meridian Bioscience traded at $30.90 this Friday July 1st, increasing $0.48 or 1.58 percent since the previous trading session. Looking back, over the last four weeks, Meridian Bioscience gained 12.61 percent. Over the last 12 months, its price rose by 40.77 percent. Looking ahead, we forecast Meridian Bioscience to be priced at 30.06 by the end of this quarter and at 27.68 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 110.22 1.57 1.45% -6.62%
Atrion 635.68 6.82 1.08% 5.42%
Accelerate Diagnostics 1.04 0.05 4.76% -86.92%
Becton, Dickinson and Co. 251.80 5.27 2.14% 1.35%
Bio-Rad Laboratories 502.34 7.34 1.48% -24.66%
Cerus 5.48 0.19 3.59% -2.32%
Myriad Genetics 18.63 0.46 2.53% -40.48%
Neogen 24.30 0.21 0.87% -47.29%
OraSure Technologies 2.72 0.01 0.37% -73.36%
Quidel 97.11 -0.07 -0.07% -22.49%
Rockwell Medical 1.28 -0.01 -0.78% 48.41%
Sientra 0.84 0.002 0.27% -89.47%
STAAR Surgical 72.19 1.26 1.78% -50.12%
Thermo Fisher Scientific 548.27 4.99 0.92% 6.81%
Trinity Biotech 1.32 0.10 7.76% -53.02%
Utah Medical Products 84.74 -1.16 -1.35% -0.67%
Meridian Bioscience 30.90 0.48 1.58% 40.77%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%

Meridian Bioscience
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The Company's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi' in, Israel. The segment also includes blood chemistry products in Billerica, Massachusetts and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany; and the sale and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, and bioresearch reagents domestically and abroad.